Maintenance of Sustained Low Disease Activity or Remission in Patients With Rheumatoid Arthritis Treated With Etanercept Monotherapy: Results from the Corrona Registry
Author:
Affiliation:
1. Corrona, LLC, Waltham, Massachusetts, and Columbia University College of Physicians and Surgeons New York New York
2. Corrona, LLC Waltham Massachusetts
3. DOCS Global, Inc. North Wales Pennsylvania
4. Amgen Inc. Thousand Oaks California
Publisher
Wiley
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr2.11168
Reference21 articles.
1. Rheumatoid arthritis;Spector TD;Rheum Dis Clin North Am,1990
2. Is the incidence of rheumatoid arthritis rising?: Results from Olmsted County, Minnesota, 1955-2007
3. Incidence, Prevalence, Costs, and Impact on Disability of Common Conditions Requiring Rehabilitation in the United States: Stroke, Spinal Cord Injury, Traumatic Brain Injury, Multiple Sclerosis, Osteoarthritis, Rheumatoid Arthritis, Limb Loss, and Back Pain
4. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
5. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Canadian Retrospective Chart Review Evaluating Concomitant Methotrexate De-escalation Patterns in Patients with Rheumatoid Arthritis Treated with Biologic or Targeted Synthetic DMARDs;Rheumatology and Therapy;2024-07-08
2. Rational approach to the prescription of anti-rheumatic drugs in rheumatoid arthritis: a product leaflet-based strategy in Italy;Frontiers in Immunology;2024-06-24
3. Methotrexate in early rheumatoid arthritis: Is the anchor drug still holding?;Autoimmunity Reviews;2022-04
4. Rémission dans la polyarthrite rhumatoïde : quelle désescalade ?;L'actualité Rhumatologique 2022;2022
5. Demographic and Clinical Characteristics of Patients with Sustained and Switching Treatments Using Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs: A Multicenter, Observational Cross-Sectional Study for Rheumatoid Arthritis;Rheumatology and Therapy;2021-12-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3